Skip to content
healthcare.dev

BRINZOLAMIDE

NDC 68682-464, brinzolamide, suspension/ drops, from Oceanside Pharmaceuticals..

Product NDC
68682-464
Status
Listed
Labeler
Oceanside Pharmaceuticals.
Dosage form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204884
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68682-464 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BRINZOLAMIDE10 mg/mL

Pharmacologic classes

Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]

Package NDCNDC-11Package
68682-464-10686820464101 BOTTLE, PLASTIC in 1 CARTON (68682-464-10) / 10 mL in 1 BOTTLE, PLASTIC
68682-464-15686820464151 BOTTLE, PLASTIC in 1 CARTON (68682-464-15) / 15 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fb7229d4-522e-4cb2-b513-9d34f3ded591

Use it

Look up 68682-464 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68682-464 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68682-464. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.